[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
November 20, 2002

Questions About Hormone Therapy Remain Puzzling

Author Affiliations

Not Available

Not Available

JAMA. 2002;288(19):2395-2396. doi:10.1001/jama.288.19.2395-JMN1120-2-1

Chicago—New clinical recommendations from the North American Menopause Society (NAMS) show that many physicians are left with more questions than answers following the recent release of data from two large clinical trials of hormone replacement therapy (HRT).

After the publication of follow-up findings from the Heart and Estrogen/progestin Replacement Study (HERS II) and a halted arm of the Women's Health Initiative (WHI), the NAMS board faced two issues: whether to respond to the findings and, if so, how best to guide clinicians who prescribe HRT.

First Page Preview View Large
First page PDF preview
First page PDF preview